Publication

Byline

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... और पढ़ें


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety... और पढ़ें


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Mo... और पढ़ें


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in... और पढ़ें


Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and e... और पढ़ें


Kohinoor Foods to table results

Mumbai, Aug. 7 -- Kohinoor Foods will hold a meeting of the Board of Directors of the Company on 13 August 2026. Published by HT Digital Content Services with permission from Capital Market.... और पढ़ें


RI develops water technologies to tackle stronger El Nino

Jakarta, Aug. 7 -- Indonesia's National Research and Innovation Agency (BRIN) is advancing weather modification, desalination, and water purification technologies to strengthen water security as a str... और पढ़ें


Sparkle Gold Rock to conduct board meeting

Mumbai, Aug. 7 -- Sparkle Gold Rock will hold a meeting of the Board of Directors of the Company on 11 August 2026. Published by HT Digital Content Services with permission from Capital Market.... और पढ़ें


Aeonx Digital Technology to announce Quarterly Result

Mumbai, Aug. 7 -- Aeonx Digital Technology will hold a meeting of the Board of Directors of the Company on 12 August 2026. Published by HT Digital Content Services with permission from Capital Market... और पढ़ें


Genus Power Infrastructures to announce Quarterly Result

Mumbai, Aug. 7 -- Genus Power Infrastructures will hold a meeting of the Board of Directors of the Company on 13 August 2026. Published by HT Digital Content Services with permission from Capital Mar... और पढ़ें